Pfizer Inc.
PFE
$25.88
$0.140.54%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 2.97B | 410.00M | 4.47B | 41.00M |
| Total Depreciation and Amortization | -- | 1.61B | 1.79B | 1.75B | 1.73B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -327.00M | 1.60B | -377.00M | -14.00M |
| Change in Net Operating Assets | -- | -1.92B | 2.93B | 879.00M | -3.54B |
| Cash from Operations | -- | 2.34B | 6.72B | 6.71B | -1.78B |
| Capital Expenditure | -- | -564.00M | -917.00M | -651.00M | -637.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 3.84B | -706.00M | -1.41B | 5.24B |
| Cash from Investing | -- | 3.27B | -1.62B | -2.06B | 4.60B |
| Total Debt Issued | -- | -- | 732.00M | 2.16B | 4.57B |
| Total Debt Repaid | -- | -2.43B | -3.45B | -4.41B | -4.59B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -2.44B | -2.38B | -2.38B | -2.38B |
| Other Financing Activities | -- | -356.00M | -14.00M | -6.00M | -63.00M |
| Cash from Financing | -- | -5.23B | -5.11B | -4.64B | -2.46B |
| Foreign Exchange rate Adjustments | -- | -7.00M | -29.00M | 9.00M | -18.00M |
| Miscellaneous Cash Flow Adjustments | -- | -1.00M | -- | -1.00M | 1.00M |
| Net Change in Cash | -- | 374.00M | -45.00M | 29.00M | 343.00M |